Cardiogenic shock is a high-acuity, potentially complex, and hemodynamically diverse state
of end-organ hypoperfusion that is frequently associated with multisystem organ failure …

Cardiogenic shock (CS) remains the most common cause of death in patients with acute
myocardial infarction although mortality could be reduced from formerly∼ 80% to 40–50 …

and management remains challenging despite advances in therapeutic options. CS is
caused by severe impairment of myocardial performance that results in diminished cardiac …

The prevalence and public health burden of chronic heart failure (CHF) in Europe is steadily
increasing mainly caused by the ageing population and prolonged survival of patients with …

Background: Recent trials demonstrated a benefit of multivessel percutaneous coronary
intervention (PCI) for noninfarct-related artery (non-IRA) stenosis over IRA-only PCI in …

Background In acute myocardial infarction complicated by cardiogenic shock (CS), up to
80% of patients present with multivessel coronary artery disease. Currently, the best …

Objectives: This study sought to assess the impact of multivessel (MV) primary percutaneous
coronary intervention (PCI) on clinical outcomes in patients with ST-segment elevation …

Background Early revascularisation of the culprit lesion is the therapeutic cornerstone in
cardiogenic shock complicating acute myocardial infarction. The optimal management of …

Myocardial infarction (MI) complicated by cardiogenic shock (MI-CS) is a major cause of
cardiovascular morbidity and mortality. Predictors of outcomes in MI-CS include clinical …

Multivessel disease (MVD) affects approximately 50% of patients with acute coronary
syndromes (ACS) and is significantly burdened by poor outcomes and high mortality. It …